Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure

Cutaneous and Ocular Toxicology

Volumn 27, Issue 3, 2008, Pages 203-211

  Panahi, Yunes ^a   Davoudi, Seyyed Masoud ^a   Moharamzad, Yashar ^a   Beiraghdar, Fatemeh ^a   Naghizadeh, Mohammad Mehdi ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Betamethasone; Capsaicin; Chronic skin lesions; Pruritus; Sulfur mustard

Indexed keywords

BETAMETHASONE; CAPSAICIN; MUSTARD GAS;

ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRY SKIN; ECZEMA; ERYTHEMA; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INTOLERABLE ODOR; LICHENOID ERUPTION; MAJOR CLINICAL STUDY; MALE; PRURITUS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SKIN DEFECT; SKIN FISSURE; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; BETAMETHASONE; CAPSAICIN; CHRONIC DISEASE; HUMANS; MALE; MIDDLE AGED; MUSTARD GAS; PRURITUS; SKIN; SKIN DISEASES;

EID: 55749108709     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520802143519     Document Type: Article

References (28)

1. Wormser U. Toxicology of mustard gas. Trends Pharmacol Sci 1991; 12:164-167.
2. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006; 99:273-282.
3. Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol 1991; 127:1207-1213.
4. Reports of specialists appointed by the Secretary General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons. New York: Security Council of the United Nations document S/16433. 1986.
5. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard gas. J Occup Environ Med 2003; 45:1136-1143.
6. Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 2004; 16:491-495.
7. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol 2007; 19:451-456.
8. Balali-Mood M. First report of delayed toxic effects of Yperite poisoning in Iranian fighters. In: Heyndrickx B, ed. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare: Toxicological Evaluation; Ghent, Belgium: Ghent University Press. 1986:489-495.
9. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, Razavi ME, Zare G, Jafaari MR, Tabatabaee A. Long-term complications of sulfur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005; 19:713-721.
10. Rice P. Sulphur mustard injuries of the skin. Pathophysiology and management. Toxicol Rev 2003; 22:111-118.
11. Henqque UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54:1-15.
12. Schoepe S, Schacke H, May E, Asadullah K. Glucocorticoid therapy-induced skin atrophy. Exp Dermatol 2006; 15:406-420.
13. Weisshaar E, Heyer G, Forster C, Handwerker HO. Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin. Arch Dermatol Res 1998; 290:306-311.
14. Weisshaar E, Dunker N, Gollnick H. Topical capsaicin therapy in humans with hemodialysis-related pruritus. Neurosci Lett 2003; 345:192-194.
15. Stander S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 2001; 44:471-478.
16. Reimann S, Luger T, Metze D. Topical administration of capsaicin in dermatology for treatment of itching and pain. Hautarzt 2000; 51:164-172.
17. Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 1998; 78:395-402.
18. Long CC, Finlay AY. The finger-tip unit: a new practical measure. Clin Exp Dermatol 1991; 16:444-447.
19. Momeni AZ, Aminjavaheri M. Skin manifestations of mustard gas in a group of 14 children and teenagers: a clinical study. Int J Dermatol 1994; 33:184-187.
20. Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. Arch Dermatol 1992; 128:775-780.
21. Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol 2006; 45:1025-1031.
22. Shohrati M, Davoudi M, Ghanei M, Peyman M, Peyman A. Cutaneous and ocular late complications of sulfur mustard in Iranian veterans. Cutan Ocul Toxicol 2007; 26(2):73-81.
23. Arroyo CM, Schafer RJ, Kurt EM, Broomfield CA, Carmichael AJ. Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a nonenzymatic detachment procedure. Hum Exp Toxicol 1999; 18:1-11.
24. Arroyo CM, Schafer RJ, Kurt EM, et al. Response of normal human keratinocytes to sulfur mustard: cytokine release. J Appl Toxicol 2000; 20(Suppl 1):S63-S72.
25. Shohrati M, Tajik A, Harandi AA, Davoodi SM, Almasi M. Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. Skinmed 2007; 6:70-72.
26. Burks TF, Buck SH, Miller MS. Mechanisms of depletion of substance P by capsaicin. Fed Proc 1985; 44:2531-2534.
27. Weisshaar E, Heyer G, Forster C, Handwerker HO. Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin. Arch Dermatol Res 1998; 290:306-311.
28. Panahi Y, Davoodi SM, Khalili H, Dashti-Khavidaki S, Bigdeli M. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med J 2007; 48:392-395.